...is president and CEO of Vivet Therapeutics, and was COO of GenSight Biologics S.A.Ophthalmic company Tarsus Pharmaceuticals Inc....

...developing oligonucleotides and small molecules for HBV, liver diseases including non-alcoholic steatohepatitis (NASH) and SARS-CoV-2 infection. Tarsus Pharmaceuticals Inc....
...endothelial growth factor CVEGF-D - Vascular endothelial growth factor D Paul Bonanos Aligos Therapeutics Inc. Praxis Precision Medicines Inc. Tarsus Pharmaceuticals Inc....

...unit. He was SVP, head of global clinical operations at Autolus Therapeutics plc (NASDAQ:AUTL).Ophthalmology company Tarsus Pharmaceuticals Inc....
...was senior medical director at Johnson & Johnson (NYSE:JNJ). Robin Sawka Novocure Ltd. Werewolf Therapeutics Jasper Therapeutics Inc. Avacta Group plc Tarsus Pharmaceuticals Inc. Bicycle...

...at Insulet Corp. ViaCyte is developing cell replacement therapies for patients with diabetes. Ophthalmology company Tarsus Pharmaceuticals Inc....
...LogicBio Therapeutics Inc. (NASDAQ:LOGC). Robin Sawka, BioCentury Staff ViaCyte Inc. Ribon Therapeutics Inc. Innate Pharma S.A. Kiadis Pharma N.V. Zikani Therapeutics Inc. Tarsus Pharmaceuticals Inc. MaaT...

...to many possibilities and is generally agnostic to therapeutic areas. He pointed to ophthalmic play Tarsus Pharmaceuticals Inc....

...included Frazier Healthcare Partners, Flying L Partners, Visionary Ventures, Aperture Venture Partners and Horowitz Group. Tarsus Pharmaceuticals Inc....
...undisclosed series A round from one of the company's series B investors. Karen Tkach Tuzman, Associate Editor Tarsus Pharmaceuticals Inc. blepharitis Demodex...